Bristol-Myers Squibb (NYSE:BMY) will release its Q3 2014 results on October 24th. We expect strong performance from its key drugs Eliquis and Yervoy. Additionally, the anti-viral drugs business will see the impact of the approval of the HCV drug Daklinza in Europe and Japan. Overall, we expect reasonable growth for Bristol-Myers Squibb. Additionally, the recent HCV approval and the expected approval of its immuno-oncology drug Nivolumab are something to cheer about and could support the company’s growth over next 5-6 years. Here is what the investors can expect from Bristol-Myers Squibb’s upcoming earnings. Bristol-Myers Squibb Company (NYSE:BMY) in last trading activity advanced 1.27% to close at $52.50. Company weekly performance is 6.66% while its quarterly performance stands at 7.06%. Bristol-Myers Squibb Company (NYSE:BMY) is -6.70% away from its 52 week high.Semiconductor company TriQuint Semiconductor, Inc. (NASDAQ:TQNT) used NI's AWS Microwave Office and Visual System Simulator software tools to design an Edge/GSM power amplifier for use in a mobile handset, accurately characterising the amplifier's circuit performance at system level, and predicting adjacent channel power ratio measurements (ACPR) to minimise the effect of spectral spreading to ensure compliance. On last trading day TriQuint Semiconductor, Inc. (NASDAQ:TQNT) advanced 2.87% to close at $17.55. Its volatility for the week is 4.32% while volatility for the month is 5.20%. TQNT's sales growth for past 5 years was 9.30% and its EPS growth for past 5 years was -19.10%. TriQuint Semiconductor, Inc. (NASDAQ:TQNT) monthly performance is -12.34%.Energy Transfer Equity, L.P. (NYSE:ETE)’s Director Kelcy L. Warren acquired 1,178,567 shares of the stock in a transaction dated Tuesday, October 14th. The shares were purchased at an average cost of $51.30 per share, for a total transaction of $60,460,487.10. On last trading day Energy Transfer Equity, L.P. (NYSE:ETE) decreased -0.91% to close at $57.71. Its volatility for the week is 3.39% while volatility for the month is 5.99%. ETE's sales growth for past 5 years was 39.10% and its EPS growth for past 5 years was -19.20%. Energy Transfer Equity, L.P. (NYSE:ETE) monthly performance is -5.75%.Dillard's Inc. (NYSE:DDS) EVP Drue Matheny sold 10,000 shares of the company’s stock in a transaction that occurred on Tuesday, October 14th. The shares were sold at an average price of $103.45, for a total transaction of $1,034,500.00. Following the transaction, the executive vice president now directly owns 39,030 shares in the company, valued at approximately $4,037,654.Dillard's Inc. (NYSE:DDS) has 10.60% insider ownership while its institutional ownership stands at 92.80%. In last trading activity company's stock closed at $108.05.Jewellery retailers Cartier and Tiffany & Co (NYSE:TIF) have once again made it into a global ranking of the world’s best brands. This year, Cartier and Tiffany & Co. (NYSE:TIF) were the only jewellery companies that made the list, with both having increased positions from 2013. Tiffany’s listing lifted from 75 to 71 and its brand value increased 9 per cent from US$5.4 billion (AU$6.2 b) to US$5.9 billion (AU$6.8 b). This was a slight increase from the previous year when its brand value rose 5 per cent. On Thursday shares of Tiffany & Co. (NYSE:TIF) closed at $94.40. Company's sales growth for last 5 years was 7.20% and EPS growth for next 5 years is recorded as 11.76%.
Discover Hidden Gems
Don't miss the next big opportunity. Subscribe for timely alerts on potential market movers.
